Search
Dibusadol
go.drugbank.com/drugs/DB21013ExperimentalDibusadol is a small molecule drug. The usage of the INN stem '-adol/-adol-' in the name indicates that Dibusadol is a analgesic. Dibusadol has a monoisotopic molecular weight of 306.19 Da.
Mezepine
go.drugbank.com/drugs/DB21047ExperimentalMezepine is a small molecule drug. The usage of the INN stem '-zepine' in the name indicates that Mezepine is a tricyclic compound. Mezepine has a monoisotopic molecular weight of 266.18 Da.
Etarotene
go.drugbank.com/drugs/DB21071ExperimentalEtarotene is a small molecule drug. The usage of the INN stem '-arotene' in the name indicates that Etarotene is a arotinoid derivative. Etarotene has a monoisotopic molecular weight of 396.21 Da.
Gestaclone
go.drugbank.com/drugs/DB21090ExperimentalGestaclone is a small molecule drug. The usage of the INN stem '-clone' in the name indicates that Gestaclone is a hypnotic tranquillizer. Gestaclone has a monoisotopic molecular weight of 370.17 Da.
Pinolcaine
go.drugbank.com/drugs/DB21159ExperimentalPinolcaine is a small molecule drug. The usage of the INN stem '-caine' in the name indicates that Pinolcaine is a local anaesthetic. Pinolcaine has a monoisotopic molecular weight of 351.22 Da.
Lorcinadol
go.drugbank.com/drugs/DB21160ExperimentalLorcinadol is a small molecule drug. The usage of the INN stem '-adol/-adol-' in the name indicates that Lorcinadol is a analgesic. Lorcinadol has a monoisotopic molecular weight of 314.13 Da.
Linarotene
go.drugbank.com/drugs/DB21165ExperimentalLinarotene is a small molecule drug. The usage of the INN stem '-arotene' in the name indicates that Linarotene is a arotinoid derivative. Linarotene has a monoisotopic molecular weight of 398.2 Da.
AICA ribonucleotide
go.drugbank.com/drugs/DB01700Investigational5-Aminoimidazole-4-carboxamide ribonucleotide (AICAR) is an intermediate in the generation of inosine monophosphate and analog of adenosine monophosphate (AMP) that is capable of stimulating AMP-dependent … The drug was first used in the 1980s as a method to preserve blood flow to the heart during surgery and is currently of interest as a potential treatment for diabetes by increasing the metabolic activity
Englumafusp alfa
go.drugbank.com/drugs/DB19341InvestigationalEnglumafusp alfa is under investigation in clinical trial NCT04077723 (A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-tumor Activity of Englumafusp Alfa in Combination With Obinutuzumab … and in Combination With Glofitamab Following a Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/refractory B-cell Non-hodgkin's Lymphoma).